Why the study?
Optimal pharmacological and treatment strategies for right heart failure and conduit dysfunction in late-phase post-Rastelli adult congenital heart disease patients are not well understood.
Combined surgical intervention and modern heart failure pharmacotherapy (including ivabradine, vericiguat, and SGLT2 inhibitors) can successfully improve biventricular function in complex adult congenital heart disease.
May support combined conduit surgery plus GDMT for biventricular recovery in select post-Rastelli ACHD HF; leaves open optimal regimens.
Background: Advances in medical treatments have allowed many congenital heart disease patients to reach adulthood, resulting in an increase in adult congenital heart disease (ACHD) cases. Managing heart failure (HF) in ACHD patients is a significant concern, particularly due to limited understanding of optimal pharmacological therapies. Conduit dysfunction and right heart failure are common in the late phase after the Rastelli procedure, but right HF is not well understood, and standard medications for acquired HF are not particularly effective. Consequently, there is a knowledge gap regarding optimal treatment strategies. Case summary: We report the case of a 19-year-old woman with a history of Blalock-Taussig shunt, Rastelli procedure, and reoperation for conduit stenosis. She was diagnosed with chronic active Epstein-Barr virus infection and admitted due to exertional dyspnoea and orthopnoea. On admission, she exhibited signs of acute HF with severe left ventricular dysfunction and conduit stenosis. Initial management with diuretics was insufficient, requiring inotropic support. Right heart catheterization revealed conduit failure, necessitating surgical replacement. Postoperatively, optimized medical therapy, including beta-blockers, ivabradine, vericiguat, and SGLT-2 inhibitors, was administered. Over several months, her biventricular function improved significantly, and she underwent umbilical cord blood transplantation for EBV infection, with a favourable outcome. Discussion: This case highlights the importance of combining surgical and pharmacological strategies in managing complex ACHD with biventricular dysfunction. Identifying underlying causes, such as chronic myocarditis due to EBV infection, is crucial. Ivabradine allowed for beta-blocker increase, and with newer agents like vericiguat and SGLT-2 inhibitors, significantly improved cardiac function.
No takes yet. Share an insight, caveat, or question.
Kashimura et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: